2005
DOI: 10.1016/j.bios.2004.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Home blood glucose biosensors: a commercial perspective

Abstract: Twenty years on from a review in the first

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
336
0
6

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 787 publications
(355 citation statements)
references
References 7 publications
0
336
0
6
Order By: Relevance
“…ET can be achieved directly (direct electron transfer, DET) or by the use of mediators (mediated electron transfer, MET) to shuttle electrons between the redox centre of the enzyme and the electrode. However, mediators are unselective and can also give rise to interfering effects [1][2][3]. DET-based devices offer high selectivity and sensitivity due to the absence of mediators.…”
mentioning
confidence: 99%
“…ET can be achieved directly (direct electron transfer, DET) or by the use of mediators (mediated electron transfer, MET) to shuttle electrons between the redox centre of the enzyme and the electrode. However, mediators are unselective and can also give rise to interfering effects [1][2][3]. DET-based devices offer high selectivity and sensitivity due to the absence of mediators.…”
mentioning
confidence: 99%
“…Glucose diffuses from capillaries through the sensor membrane, which is semi-permeable, and acts as the interface between the enzymes and electrode. Failures occur from biocompatibility issues such as membrane biofouling, fibrous encapsulation, electrode passivation and biodegradation [60]. Membrane biofouling starts upon bodily contact when micro-organisms, proteins and other components adhere to the surface, impeding the sensor's diffusion ability.…”
Section: (C) Temporary Implantsmentioning
confidence: 99%
“…Several commercial examples for biosensing platforms exist including point-of-use type kits such as home pregnancy tests for detection of hormones such as human chorionic gonadotropin (hCG) for early indication of pregnancy. Another familiar example of a commercially available portable biosensor is a home blood glucose meter for diabetics [63]. It is expected that with smaller volumes, higher specificity for detection can be achieved with the eventual goal of single-molecule detection.…”
Section: (B) Microfluidic and Nanofluidic Biosensor Platformsmentioning
confidence: 99%